Drug
Olaparib
Data on this page refer exclusively to patients treated with
Olaparib combined with SBRT, without concurrent use of
drugs from other classes.
Combination therapy data and pooled group-level evidence are available on the
PARP inhibitor group page.
Drug Profile
| Therapeutic Class | Targeted Therapy |
| Drug Class | PARP Inhibitors |
| Group | PARP inhibitor |
| Mechanism of Action | PARP inhibitor |
| Half-life | 15 h |
Location
Treated site
